|
|
Thomas Ichim, CEOMedistem's mission is to discover, develop and commercialize technologies related to adult stem cell extraction and manipulation for use in treating inflammatory and degenerative diseases. The company has a portfolio of products in various stages of development covered by 15 families of patent applications.
|
|||
|
|
||||




